NO951146L - Sulfonamidokarbonylpyridin-2-karboksylsyreamider samt deres pyridin-N-oksyd, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel - Google Patents

Sulfonamidokarbonylpyridin-2-karboksylsyreamider samt deres pyridin-N-oksyd, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel

Info

Publication number
NO951146L
NO951146L NO951146A NO951146A NO951146L NO 951146 L NO951146 L NO 951146L NO 951146 A NO951146 A NO 951146A NO 951146 A NO951146 A NO 951146A NO 951146 L NO951146 L NO 951146L
Authority
NO
Norway
Prior art keywords
alkyl
opt
bond
substd
alkoxy
Prior art date
Application number
NO951146A
Other languages
English (en)
Other versions
NO951146D0 (no
NO304308B1 (no
Inventor
Klaus Weidmann
Martin Bickel
Volkmar Gunzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO951146D0 publication Critical patent/NO951146D0/no
Publication of NO951146L publication Critical patent/NO951146L/no
Publication of NO304308B1 publication Critical patent/NO304308B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
NO951146A 1994-03-25 1995-03-24 Sulfonamidokarbonylpyridin-2-karboksylsyreamider samt deres pyridin-N-oksyder og deres anvendelse for fremstilling av legemiddel NO304308B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4410423A DE4410423A1 (de) 1994-03-25 1994-03-25 Sulfonamidocarbonylpyridin-2-carbonsäureamide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (3)

Publication Number Publication Date
NO951146D0 NO951146D0 (no) 1995-03-24
NO951146L true NO951146L (no) 1995-09-26
NO304308B1 NO304308B1 (no) 1998-11-30

Family

ID=6513863

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951146A NO304308B1 (no) 1994-03-25 1995-03-24 Sulfonamidokarbonylpyridin-2-karboksylsyreamider samt deres pyridin-N-oksyder og deres anvendelse for fremstilling av legemiddel

Country Status (19)

Country Link
US (1) US5610172A (no)
EP (1) EP0673931B1 (no)
JP (1) JPH07278109A (no)
KR (1) KR950032124A (no)
CN (1) CN1114312A (no)
AT (1) ATE156815T1 (no)
AU (1) AU689199B2 (no)
CA (1) CA2145476A1 (no)
CZ (1) CZ287768B6 (no)
DE (2) DE4410423A1 (no)
DK (1) DK0673931T3 (no)
ES (1) ES2105798T3 (no)
FI (1) FI951386L (no)
GR (1) GR3024860T3 (no)
HU (1) HUT72059A (no)
NO (1) NO304308B1 (no)
NZ (1) NZ270783A (no)
PL (1) PL180042B1 (no)
ZA (1) ZA952408B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191368B1 (en) 1995-09-12 2001-02-20 Tessera, Inc. Flexible, releasable strip leads
EP2295060B1 (en) 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions
CN102526045A (zh) * 2001-12-06 2012-07-04 法布罗根股份有限公司 提高内源性红细胞生成素(epo)的方法
US20040158289A1 (en) * 2002-11-30 2004-08-12 Girouard Steven D. Method and apparatus for cell and electrical therapy of living tissue
US8124582B2 (en) 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
US7618940B2 (en) 2002-12-06 2009-11-17 Fibrogen, Inc. Fat regulation
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US7764995B2 (en) * 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
US7828711B2 (en) * 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US8060219B2 (en) * 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
ATE470439T1 (de) 2005-06-15 2010-06-15 Fibrogen Inc Verwendung von hif 1alfa modulatoren zur behandlung von krebs
US7774057B2 (en) 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
KR100959538B1 (ko) * 2006-03-30 2010-05-27 엘지전자 주식회사 비디오 신호를 디코딩/인코딩하기 위한 방법 및 장치
NZ601730A (en) 2006-06-26 2014-04-30 Akebia Therapeutics Inc Prolyl hydroxylase inhibitors and methods of use
WO2009002533A1 (en) * 2007-06-27 2008-12-31 The Brigham And Women's Hospital, Inc. Inflammatory bowel disease therapies
NO2686520T3 (no) 2011-06-06 2018-03-17
SMT202400092T1 (it) 2013-06-13 2024-05-14 Akebia Therapeutics Inc Composizioni e metodi per il trattamento dell'anemia
EP3578546A1 (en) 2013-11-15 2019-12-11 Akebia Therapeutics Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
HK1247201A1 (zh) 2015-01-23 2018-09-21 阿克比治疗有限公司 2-(5-(3-氟苯基)-3-羟基吡啶甲醯胺)乙酸的固体形式、其组合物及用途
PL3277270T3 (pl) 2015-04-01 2022-02-14 Akebia Therapeutics, Inc. Kompozycje i sposoby leczenia niedokrwistości
CA3097219A1 (en) 2018-05-09 2019-11-14 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
US12612367B2 (en) 2019-12-10 2026-04-28 Akebia Therapeutics, Inc. Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW352384B (en) * 1992-03-24 1999-02-11 Hoechst Ag Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals

Also Published As

Publication number Publication date
CZ73395A3 (en) 1995-11-15
HUT72059A (en) 1996-03-28
ZA952408B (en) 1995-11-27
FI951386A7 (fi) 1995-09-26
ATE156815T1 (de) 1997-08-15
FI951386L (fi) 1995-09-26
US5610172A (en) 1997-03-11
AU1504295A (en) 1995-10-05
DK0673931T3 (da) 1998-03-16
HU9500865D0 (en) 1995-05-29
DE59500488D1 (de) 1997-09-18
FI951386A0 (fi) 1995-03-23
PL307848A1 (en) 1995-10-02
JPH07278109A (ja) 1995-10-24
NO951146D0 (no) 1995-03-24
NZ270783A (en) 1997-02-24
GR3024860T3 (en) 1998-01-30
EP0673931A1 (de) 1995-09-27
KR950032124A (ko) 1995-12-20
CA2145476A1 (en) 1995-09-26
PL180042B1 (en) 2000-12-29
CN1114312A (zh) 1996-01-03
HK1012338A1 (en) 1999-07-30
DE4410423A1 (de) 1995-09-28
CZ287768B6 (en) 2001-01-17
ES2105798T3 (es) 1997-10-16
EP0673931B1 (de) 1997-08-13
NO304308B1 (no) 1998-11-30
AU689199B2 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
NO951146D0 (no) Sulfonamidokarbonylpyridin-2-karboksylsyreamider samt deres pyridin-N-oksyd, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel
NO951149D0 (no) Sulfonamidokarbonylpyridin-2-karboksylsyreesteramider samt deres pyridin-N-oksyd, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel
EP1404368B1 (en) Mutant forms of cholera holotoxin as an adjuvant
DK414488A (da) Substituerede quinolinderivater, fremgangsmaade til deres fremstilling samt farmaceutiske midler indeholdende disse forbindelser
ZA903804B (en) A method of potentiating cell-mediated immunity utilizing polyamine derivatives
IL109547A0 (en) Substituted pyrroles, their preparation and pharmaceutical compositions containing them
ZA905799B (en) Control of scale in aqueous systems using certain phosphonomethyl amine oxides
PT84814A (en) 3-hydroxypyridines
GR3002416T3 (en) Derivatives of glutamic acid, their salts, process for their preparation, use as medicines and compositions containing them
IL81258A (en) Dihydropyridinelactols,their preparation and pharmaceutical compositions containing them
GR3037037T3 (en) Substituted 7,12-dioxabenzo(a)anthracene derivatives, process for their preparation and pharmaceutical compositions containing them
DE3681432D1 (de) 4-thienyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln.
GB1425154A (en) Pyridoquinoline derivatives
EP0107907A3 (en) Improvements in or relating to immunomodulating agents
HUT48893A (en) Process for producing new cepheme derivatives
UA27250C2 (uk) Антибіотична композиція
ES525010A0 (es) Un metodo de preparar una forma solida, estable y soluble en agua de 3-desazaguanina
HUP9701381A2 (hu) Új 7,8-dihidro-8,8-diszubsztituált-9H-1,3-dioxolo-[4,5-h][2,3]-benzodiazepin-származékok, ilyen hatóanyagot tartalmazó gyógyászati készítmény, és eljárás a hatóanyag előállítására

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003